Top segments and regional performance

Last year, the company generated ‪233.80 M‬ USD, the most of which — ‪206.13 M‬ USD — came from its top-performing segment, INTERCEPT Blood System, compared to ‪180.27 M‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪124.72 M‬ USD last year, with ‪111.07 M‬ USD the year before.